Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L
- PMID: 36678554
- PMCID: PMC9860663
- DOI: 10.3390/ph16010058
Current Knowledge of the Antidepressant Activity of Chemical Compounds from Crocus sativus L
Abstract
Psychotropic effect of Crocus sativus L. (family Iridaceae) biologically active chemical compounds are quite well documented and they can therefore be used in addition to the conventional pharmacological treatment of depression. This systematic review on antidepressant compounds in saffron crocus and their mechanisms of action and side effects is based on publications released between 1995−2022 and data indexed in 15 databases under the following search terms: antidepressant effect, central nervous system, Crocus sativus, cognitive impairement, crocin, crocetin, depression, dopamine, dopaminergic and serotonergic systems, picrocrocin, phytotherapy, neurotransmitters, safranal, saffron, serotonin, and biologically active compounds. The comparative analysis of the publications was based on 414 original research papers. The investigated literature indicates the effectiveness and safety of aqueous and alcoholic extracts and biologically active chemical compounds (alkaloids, anthocyanins, carotenoids, flavonoid, phenolic, saponins, and terpenoids) isolated from various organs (corms, leaves, flower petal, and stigmas) in adjuvant treatment of depression and anxiety. Monoamine reuptake inhibition, N-methyl-d-aspartate (NMDA) receptor antagonism, and gamma-aminobutyric acid (GABA)-α agonism are the main proposed mechanism of the antidepressant action. The antidepressant and neuroprotective effect of extract components is associated with their anti-inflammatory and antioxidant activity. The mechanism of their action, interactions with conventional drugs and other herbal preparations and the safety of use are not fully understood; therefore, further detailed research in this field is necessary. The presented results regarding the application of C. sativus in phytotherapy are promising in terms of the use of herbal preparations to support the treatment of depression. This is particularly important given the steady increase in the incidence of this disease worldwide and social effects.
Keywords: Iridaceae; adjuvant phytotherapy; anxiety; crocin and crocetin; depression; neuroprogression and neurotransmitters; safety of saffron treatment; saffron and safranal.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Biologically active compounds and pharmacological activities of species of the genus Crocus: A review.Phytochemistry. 2019 Jun;162:56-89. doi: 10.1016/j.phytochem.2019.02.004. Epub 2019 Mar 8. Phytochemistry. 2019. PMID: 30856530 Review.
-
Comprehensive chemotaxonomic analysis of saffron crocus tepal and stamen samples, as raw materials with potential antidepressant activity.J Pharm Biomed Anal. 2020 May 30;184:113183. doi: 10.1016/j.jpba.2020.113183. Epub 2020 Feb 18. J Pharm Biomed Anal. 2020. PMID: 32105944
-
The Pharmacological Activities of Crocus sativus L.: A Review Based on the Mechanisms and Therapeutic Opportunities of its Phytoconstituents.Oxid Med Cell Longev. 2022 Feb 14;2022:8214821. doi: 10.1155/2022/8214821. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35198096 Free PMC article. Review.
-
Effects of Corm Treatment with Cold Plasma and Electromagnetic Field on Growth and Production of Saffron Metabolites in Crocus sativus.Int J Mol Sci. 2024 Sep 27;25(19):10412. doi: 10.3390/ijms251910412. Int J Mol Sci. 2024. PMID: 39408740 Free PMC article.
-
Nutritional and health beneficial properties of saffron (Crocus sativus L): a comprehensive review.Crit Rev Food Sci Nutr. 2022;62(10):2683-2706. doi: 10.1080/10408398.2020.1857682. Epub 2020 Dec 17. Crit Rev Food Sci Nutr. 2022. PMID: 33327732 Review.
Cited by
-
Effect of a saffron extract on sleep quality in adults with moderate insomnia: A decentralized, randomized, double-blind, placebo-controlled trial.Sleep Med X. 2025 Jul 9;10:100147. doi: 10.1016/j.sleepx.2025.100147. eCollection 2025 Dec 15. Sleep Med X. 2025. PMID: 40698027 Free PMC article.
-
The Combined Effect of Green Tea, Saffron, Resveratrol, and Citicoline against Neurodegeneration Induced by Oxidative Stress in an In Vitro Model of Cognitive Decline.Oxid Med Cell Longev. 2024 Oct 1;2024:7465045. doi: 10.1155/2024/7465045. eCollection 2024. Oxid Med Cell Longev. 2024. PMID: 39380915 Free PMC article.
-
Drugs from poisonous plants: Ethnopharmacological relevance to modern perspectives.Toxicon X. 2025 Jan 28;25:100215. doi: 10.1016/j.toxcx.2025.100215. eCollection 2025 Mar. Toxicon X. 2025. PMID: 39990776 Free PMC article. Review.
-
Phytochemicals in the treatment of patients with depression: a systemic review.Front Psychiatry. 2024 Dec 9;15:1509109. doi: 10.3389/fpsyt.2024.1509109. eCollection 2024. Front Psychiatry. 2024. PMID: 39717381 Free PMC article.
-
Unveiling the therapeutic potential of prenyl motif-containing derivatives: a key structural fragment for designing antidepressant compounds.RSC Med Chem. 2025 Jul 3. doi: 10.1039/d5md00473j. Online ahead of print. RSC Med Chem. 2025. PMID: 40677840 Free PMC article. Review.
References
-
- Sadock B.J., Sadock V.A., Ruiz P. Mood disorders. In: Sadock B.J., editor. Kaplan and Sadock’s Synopsis of Psychiatry. Behavioral Sciences/Clinical Psychiatry. 11th ed. Wolters Kluwer; Philadelphia, PA, USA: 2015. pp. 347–386.
-
- Thomas E., Seedat S. The diagnosis and management of depression in the era of the DSM-5. S. Afr. Fam. Pract. 2018;22:22–28. doi: 10.4102/safp.v60i1.4829. - DOI
Publication types
LinkOut - more resources
Full Text Sources